These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 33921589)

  • 21. New quinolone- and 1,8-naphthyridine-3-carboxamides as selective CB2 receptor agonists with anticancer and immuno-modulatory activity.
    Manera C; Malfitano AM; Parkkari T; Lucchesi V; Carpi S; Fogli S; Bertini S; Laezza C; Ligresti A; Saccomanni G; Savinainen JR; Ciaglia E; Pisanti S; Gazzerro P; Di Marzo V; Nieri P; Macchia M; Bifulco M
    Eur J Med Chem; 2015 Jun; 97():10-8. PubMed ID: 25935384
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and biological evaluation of (3',5'-dichloro-2,6-dihydroxy-biphenyl-4-yl)-aryl/alkyl-methanone selective CB2 inverse agonist.
    Presley CS; Mustafa SM; Abidi AH; Moore BM
    Bioorg Med Chem; 2015 Sep; 23(17):5390-401. PubMed ID: 26275680
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enantiomeric Agonists of the Type 2 Cannabinoid Receptor Reduce Retinal Damage during Proliferative Vitreoretinopathy and Inhibit Hyperactive Microglia
    Young AP; Szczesniak AM; Hsu K; Kelly MEM; Denovan-Wright EM
    ACS Pharmacol Transl Sci; 2024 May; 7(5):1348-1363. PubMed ID: 38751621
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of binding in a transfected cell line expressing a peripheral cannabinoid receptor (CB2): identification of cannabinoid receptor subtype selective ligands.
    Showalter VM; Compton DR; Martin BR; Abood ME
    J Pharmacol Exp Ther; 1996 Sep; 278(3):989-99. PubMed ID: 8819477
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cannabinoid receptor CB2 is involved in tetrahydrocannabinol-induced anti-inflammation against lipopolysaccharide in MG-63 cells.
    Yang L; Li FF; Han YC; Jia B; Ding Y
    Mediators Inflamm; 2015; 2015():362126. PubMed ID: 25653478
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Selective Cannabinoid 2 Receptor Agonists as Potential Therapeutic Drugs for the Treatment of Endotoxin-Induced Uveitis.
    Porter RF; Szczesniak AM; Toguri JT; Gebremeskel S; Johnston B; Lehmann C; Fingerle J; Rothenhäusler B; Perret C; Rogers-Evans M; Kimbara A; Nettekoven M; Guba W; Grether U; Ullmer C; Kelly MEM
    Molecules; 2019 Sep; 24(18):. PubMed ID: 31540271
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Benzo[d]thiazol-2(3H)-ones as new potent selective CB
    Leleu-Chavain N; Baudelet D; Heloire VM; Rocha DE; Renault N; Barczyk A; Djouina M; Body-Malapel M; Carato P; Millet R
    Eur J Med Chem; 2019 Mar; 165():347-362. PubMed ID: 30583970
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Involvement of the CB
    Khan MI; Sobocińska AA; Brodaczewska KK; Zielniok K; Gajewska M; Kieda C; Czarnecka AM; Szczylik C
    BMC Cancer; 2018 May; 18(1):583. PubMed ID: 29792186
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cannabichromene is a cannabinoid CB
    Udoh M; Santiago M; Devenish S; McGregor IS; Connor M
    Br J Pharmacol; 2019 Dec; 176(23):4537-4547. PubMed ID: 31368508
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The protective effects of β-caryophyllene on LPS-induced primary microglia M
    Askari VR; Shafiee-Nick R
    Life Sci; 2019 Feb; 219():40-73. PubMed ID: 30620895
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CB2 cannabinoid receptor mediation of antinociception.
    Ibrahim MM; Rude ML; Stagg NJ; Mata HP; Lai J; Vanderah TW; Porreca F; Buckley NE; Makriyannis A; Malan TP
    Pain; 2006 May; 122(1-2):36-42. PubMed ID: 16563625
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Opposite effects of cannabinoid CB
    Li L; Dong X; Tu C; Li X; Peng Z; Zhou Y; Zhang D; Jiang J; Burke A; Zhao Z; Jin L; Jiang Y
    Br J Pharmacol; 2019 Apr; 176(7):890-905. PubMed ID: 30707759
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Celastrol is a novel selective agonist of cannabinoid receptor 2 with anti-inflammatory and anti-fibrotic activity in a mouse model of systemic sclerosis.
    Jiang X; Chen S; Zhang Q; Yi C; He J; Ye X; Liu M; Lu W
    Phytomedicine; 2020 Feb; 67():153160. PubMed ID: 31901889
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Importance of the C-1 substituent in classical cannabinoids to CB2 receptor selectivity: synthesis and characterization of a series of O,2-propano-delta 8-tetrahydrocannabinol analogs.
    Reggio PH; Wang T; Brown AE; Fleming DN; Seltzman HH; Griffin G; Pertwee RG; Compton DR; Abood ME; Martin BR
    J Med Chem; 1997 Sep; 40(20):3312-8. PubMed ID: 9379452
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The synthetic cannabinoid WIN55,212-2 mesylate decreases the production of inflammatory mediators in rheumatoid arthritis synovial fibroblasts by activating CB2, TRPV1, TRPA1 and yet unidentified receptor targets.
    Lowin T; Pongratz G; Straub RH
    J Inflamm (Lond); 2016; 13():15. PubMed ID: 27158245
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cannabinoid CB
    Olianas MC; Dedoni S; Onali P
    Life Sci; 2021 Jul; 276():119407. PubMed ID: 33794254
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Primary Macrophage Chemotaxis Induced by Cannabinoid Receptor 2 Agonists Occurs Independently of the CB2 Receptor.
    Taylor L; Christou I; Kapellos TS; Buchan A; Brodermann MH; Gianella-Borradori M; Russell A; Iqbal AJ; Greaves DR
    Sci Rep; 2015 Jun; 5():10682. PubMed ID: 26033291
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Strategies to develop selective CB
    Moir M; Lane S; Lai F; Connor M; Hibbs DE; Kassiou M
    Eur J Med Chem; 2019 Oct; 180():291-309. PubMed ID: 31319265
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro and in vivo pharmacological characterization of JTE-907, a novel selective ligand for cannabinoid CB2 receptor.
    Iwamura H; Suzuki H; Ueda Y; Kaya T; Inaba T
    J Pharmacol Exp Ther; 2001 Feb; 296(2):420-5. PubMed ID: 11160626
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The exogenous administration of CB2 specific agonist, GW405833, inhibits inflammation by reducing cytokine production and oxidative stress.
    Parlar A; Arslan SO; Doğan MF; Çam SA; Yalçin A; Elibol E; Özer MK; Üçkardeş F; Kara H
    Exp Ther Med; 2018 Dec; 16(6):4900-4908. PubMed ID: 30542446
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.